Expression of the serine protease hepsin and clinical outcome of human endometrial cancer

Anticancer Research

Volumn 28, Issue 1 A, 2008, Pages 159-164

  Matsuo, Tamaki ^a   Nakamura, Keiichiro ^a   Takamoto, Norio ^a   Kodama, Junichi ^a   Hongo, Atsushi ^a   Abrzua, Fernando ^a   Nasu, Yasutomo ^a   Kumon, Hiromi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Hepsin; Prognostic significance

Indexed keywords

HEPSIN; SERINE PROTEINASE;

ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; SERINE ENDOPEPTIDASES;

EID: 40549087264     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Annual Report of Oncology Committee of Japan Society of Obstetrics and Gynecology, Tokyo, Japan, 2006.
2. Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL and Bast RC Jr: Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 164: 15-21, 1991.
3. Borst MP, Baker W, Dixon D, Hatch KD, Shingleton HM and Miller DM: Oncogene alterations in endometrial carcinoma. Gynecol Oncol 38: 364-366, 1990.
4. Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M and Yokota J: Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Cancer Res 51: 5632-5635, 1991.
5. Rawlings ND and Barrett AJ: Families of serine peptidases. Methods Enzymol 244: 19-61, 1994.
6. Dano K, Romer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J and Lund LR: Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS 107: 120-127, 1999.
7. Johnsen M, Lund LR, Romer J, Almholt K and Dano K: Cancer invasion and tissue remodeling: Common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998.
8. Kohn EC and Liotta LA: Molecular insights into cacner invasion: Strategies for prevention and intervention. Cancer Res 55: 1856-1862, 1995.
9. Chen WT: Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49: 59-71, 1996.
10. Leytus SP, Loeb KR, Hagen FS, Kurachi K and Davie EW: A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 27: 1067-1074, 1988.
11. Kurachi K, Torres-Rosado A and Tsuji A: Hepsin. Methods Enzymol 244: 100-114, 1994.
12. Kraut J: Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem 46: 331-58, 1977.
13. Neurath H: Evolution of proteolytic enzymes. Science 224: 350-357, 1984.
14. Tsuji A, Torres-Rosado A, Arai T, Le Beau MM, Lemons RS, Chou SH and Kurachi K: Hepsin, a cell membrane-associated protease. J Biol Chem 266: 16948-16953, 1991.
15. Jack XY, Lee C and Julie C: Molecular cloning, tissue-specific expression, and celluar localization of human prostasin mRNA. J Biol Chem 270: 13483-13489, 1995.
16. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA and Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826, 2001.
17. Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M, Zhang Z, Warrington JA and Stamey TA: Hepsin and maspin are inversely expressed in laser capture microdissectioned prostste cancer. J Urol 169: 1316-1319, 2003.
18. Stamey TA, Warrington JA, Caldwell MC, Chen Z, Fan Z, Mahadevappa M, McNeal JE, Nolley R and Zhang Z: Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 166: 2171-2177, 2001.
19. Tanimoto H, Yan Y, Clarke J, Korourian S, Shigemasa K, Parmley TH, Parham GP and O'Brien TJ: Hepsin, a cell surface serine protease identified in hepatoma cells, is expressed in ovarian cancer. Cancer Res 57: 2884-2887, 1997.
20. Zacharski LR, Ornstein DL, Memoli VA, Rousseau SM and Kisiel W: Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemostasis 79: 876-877, 1998.
21. Tavassoli FA and Stratton MR: Tumor of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
22. Announcements: FIGO stages-1988 revision. Gynecol Oncol 35: 125-127, 1989.
23. Chang C and Werb Z: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11: S37-S43, 2001.
24. Del Rosso M, Fibbi G, Pucci M, D'Alessio S, Del Rosso A, Magnelli L and Chiarugi V: Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 19: 193-207, 2002.